Eastwood Bio-Medical Canada Inc Asset Resilience Ratio
Eastwood Bio-Medical Canada Inc asset resilience ratio. Eastwood Bio-Medical Canada Inc (EBM) has an Asset Resilience Ratio of 14.31% as of April 2016. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read EBM total debt and obligations for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Eastwood Bio-Medical Canada Inc (2014–2016)
Asset resilience ratio of Eastwood Bio-Medical Canada Inc from 2014 to 2016. This chart shows how Eastwood Bio-Medical Canada Inc's Asset Resilience Ratio has changed over time. See EBM free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Eastwood Bio-Medical Canada Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Eastwood Bio-Medical Canada Inc assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 0% |
| Short-term Investments | CA$506.76K | 14.31% |
| Total Liquid Assets | CA$506.76K | 14.31% |
Asset Resilience Insights
- Moderate Liquidity: Eastwood Bio-Medical Canada Inc has 14.31% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Eastwood Bio-Medical Canada Inc Industry Peers by Asset Resilience Ratio
Compare Eastwood Bio-Medical Canada Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
Biotechnology | 0.00% |
|
HLB Co. Ltd
KQ:028300 |
Biotechnology | 3.29% |
|
Tubize-Fin
BR:TUB |
Biotechnology | 2.50% |
|
Shanghai Medicilon Inc
SHG:688202 |
Biotechnology | 6.69% |
|
Blue Jet Healthcare Limited
NSE:BLUEJET |
Biotechnology | 13.81% |
|
Hangzhou Biotest Biotech Co Ltd
SHG:688767 |
Biotechnology | 0.56% |
|
Shouyao Holdings (Beijing) Co. Ltd. A
SHG:688197 |
Biotechnology | 79.76% |
|
Shenzhen Weiguang Biological Products Co Ltd
SHE:002880 |
Biotechnology | 5.52% |
Eastwood Bio-Medical Canada Inc Asset Resilience Ratio by Year (2014–2016)
Eastwood Bio-Medical Canada Inc asset resilience ratio by year from 2014 to 2016. The table below shows the annual Asset Resilience Ratio data for Eastwood Bio-Medical Canada Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2016-10-31 | 0.00% | CA$0.00 ≈ $0.00 |
CA$3.24 Million ≈ $2.35 Million |
-- |
| 2015-10-31 | 13.07% | CA$500.00K ≈ $361.69K |
CA$3.82 Million ≈ $2.77 Million |
-0.42pp |
| 2014-10-31 | 13.49% | CA$550.00K ≈ $397.86K |
CA$4.08 Million ≈ $2.95 Million |
-- |
About Eastwood Bio-Medical Canada Inc
Eastwood Bio-Medical Canada Inc. markets, develops research, and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin, which provides natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. It also offers Eleotin A 700 for the treatment for spleen deficiency, lack of appeti… Read more